Customer Testimonial | Inthrill Thrombectomy Device

Physician Discuss Benefits of Inthrill

Client: Inari
Industry: Healthcare
Video Type: Customer Testimonial
Messaging Type: Interview-Style

About This Video Project

In this video, Dr. Nicole Alonzo, a vascular surgeon at New York Presbyterian Brooklyn Methodist Hospital and chief of clinical research, discusses her experience using the Inari Indril thrombectomy sheath.

Dr. Alonzo had a patient who was unable to have TPA, a common treatment for clotted AV fistulas and grafts. This patient needed a D-clot to avoid becoming catheter dependent. Dr. Alonzo decided to try the Inthrill device, which requires zero TPA and effectively restores access for dialysis patients. This eliminates the risk of intracranial hemorrhage or bleeding from a surgical site, as TPA is not used.

The Inthrill device has a nitinol core that can mechanically disrupt even subacute clot, making it more efficient than the traditional balloon emaceration technique. On average, the procedure time is only 45 minutes and has been successfully used on over 80 patients. Inari is a company that truly listens to its physicians and is constantly innovating to improve patient outcomes.

The Inari Inthrill thrombectomy sheath is an A-fringe system that not only removes thrombus, but also allows for the advancement of stents and angioplasty of AV access. Its hydrophilic outer element makes it easy to use on patients with scarring from repeated access attempts. The Inthrill thrombectomy catheter uses a nitinol core to mechanically remove thrombus from fistulas and AV grafts.

This device is particularly beneficial for patients with end-stage renal disease who are at risk for acute thrombosis of their AV grafts. It is also used in Dr. Alonzo’s office for patients who she has created fistulas or inserted AV grafts for, as these patients have a 22% chance of thrombosis within two years. In a retrospective study, 95% of patients who underwent thrombectomy with Indril had AV grafts and had a 77% primary patency rate, with 100% secondary and assisted patency. The average procedure time was 45 minutes with minimal blood loss of only 10 cc’s.

Dr. Alonzo has been involved in research for over 15 years and has published over 50 peer-reviewed publications, including five with Inari. She has seen firsthand the success of the Indril device in maintaining access for dialysis patients. With this device, clinicians can effectively remove thrombus in a minimally invasive and safe manner, without the use of TPA. Complications are minimal and 95% of patients are able to use their access the same day.

If you are a company searching for a video production company to create similar types of videos for your business, look no further than Pennylane Productions. Our team of experts can help you showcase your products and services in a compelling and informative way. Contact us today to learn more.

See more Healthcare videos: https://plvisuals.com/industry/healthcare-video-production/

To learn more about Inari, visit: https://www.inarimedical.com/